Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 2, risks of adverse outcome in common anomalies.
Journal
Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
31
07
2021
received:
29
11
2020
accepted:
02
08
2021
pubmed:
6
9
2021
medline:
28
12
2021
entrez:
5
9
2021
Statut:
ppublish
Résumé
After diagnosis of a fetal neurological anomaly, prospective parents want to know the best and worst-case scenarios and an estimation of the risk to their infant of having an atypical developmental outcome. The literature on developmental outcomes for fetal neurological anomalies is poor: studies are characterized by retrospective design, small sample size, often no standardized assessment of development, and differing definitions of anomalies. This review provides an aide-memoir on the risks of adverse neurodevelopmental outcome for ventriculomegaly, cortical anomalies, microcephaly, macrocephaly, agenesis of the corpus callosum, posterior fossa anomalies, and myelomeningocele, to assist healthcare professionals in counselling. The data in this review should be used alongside recommendations on counselling and service design described in part 1 to provide antenatal counselling.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
23-39Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2021 Mac Keith Press.
Références
Hart AR, Vollmer B, Howe D, et al. Antenatal counselling for prospective parents whose fetus has a neurological anomaly: part 1, experiences and recommendations for service design. Dev Med Child Neurol 2021 (Forthcoming). https://doi.org/10.1111/dmcn.15022
Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Eng J Med 2012; 367: 2175-84.
Grande M, Jansen FAR, Blumenfeld YJ, et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 46: 650-8.
Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013; 41: 610-20.
Bornstein E, Berger S, Cheung SW, et al. Universal prenatal chromosomal microarray analysis: additive value and clinical dilemmas in fetuses with a normal karyotype. Am J Perinatol 2017; 34: 340-8.
Bedei I, Wolter A, Weber A, Signore F, Axt-Fliedner R. Chances and challenges of new genetic screening technologies (NIPT) in prenatal medicine from a clinical perspective: a narrative review. Genes 2021; 12: 501.
Guadagnolo D, Mastromoro G, Di Palma F, Pizzuti A, Marchionni E. Prenatal exome sequencing: background, current practice and future perspectives-a systematic review. Diagnostics 2021; 11: 224.
Chong HP, Hamilton S, Mone F, et al. Prenatal chromosomal microarray testing of fetuses with ultrasound structural anomalies: a prospective cohort study of over 1000 consecutive cases. Prenat Diagn 2019; 39: 1064-9.
Sukenik-Halevy R, Ruhrman-Shahar N, Orenstein N, et al. The diagnostic efficacy of exome data analysis using fixed neurodevelopmental gene lists: implications for prenatal setting. Prenat Diagn 2021; 41: 701-7.
Lord J, McMullan DJ, Eberhardt RY, et al. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet 2019; 393: 747-57.
Diderich KEM, Romijn K, Joosten M, et al. The potential diagnostic yield of whole exome sequencing in pregnancies complicated by fetal ultrasound anomalies. Acta Obstet Gynecol Scand 2020; 100: 1106-15.
Vora NL, Gilmore K, Brandt A, et al. An approach to integrating exome sequencing for fetal structural anomalies into clinical practice. Genet Med 2020; 22: 954-61.
Petrovski S, Aggarwal V, Giordano JL, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet 2019; 393: 758-67.
Kodabuckus SS, Quinlan-Jones E, McMullan DJ, et al. Exome sequencing for prenatal detection of genetic abnormalities in fetal ultrasound anomalies: an economic evaluation. Fetal Diagn Ther 2020; 47: 554-64.
Choy KW, Wang H, Shi M, et al. Prenatal diagnosis of fetuses with increased nuchal translucency by genome sequencing analysis. Front Genet 2019; 10: 761.
Zhou J, Yang Z, Sun J, et al. Whole genome sequencing in the evaluation of fetal structural anomalies: a parallel test with chromosomal microarray plus whole exome sequencing. Genes 2021; 12: 376.
Gray KJ, Wilkins-Haug LE, Herrig NJ, Vora NL. Fetal phenotypes emerge as genetic technologies become robust. Prenat Diagn 2019; 39: 811-7.
Ferretti L, Mellis R, Chitty LS. Update on the use of exome sequencing in the diagnosis of fetal abnormalities. Eur J Med Genet 2019; 62: 103663.
Talati AN, Gilmore KL, Hardisty EE, Lyerly AD, Rini C, Vora NL. Impact of prenatal exome sequencing for fetal genetic diagnosis on maternal psychological outcomes and decisional conflict in a prospective cohort. Genet Med 2021; 23: 713-9.
Horridge KA. Assessment and investigation of the child with disordered development. Arch Dis Child Educ Pract Ed 2011; 96: 9-20.
Pagani G, Thilaganathan B, Prefumo F. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014; 44: 254-60.
Li Z, Lv Y, He P, et al. Clinical value of prenatal MRI for diagnosis of isolated ventriculomegaly and prediction of early postnatal developmental outcomes. Prenat Diagn 2019; 39: 124-9.
Bar-Yosef O, Barzilay E, Dorembus S, Achiron R, Katorza E. Neurodevelopmental outcome of isolated ventriculomegaly: a prospective cohort study. Prenat Diagn 2017; 37: 764-8.
Chu N, Zhang Y, Yan Y, Ren Y, Wang L, Zhang B. Fetal ventriculomegaly: pregnancy outcomes and follow-ups in ten years. Biosci Trends 2016; 10: 125-32.
Thorup E, Jensen LN, Bak GS, et al. Neurodevelopmental disorder in children believed to have isolated mild ventriculomegaly prenatally. Ultrasound Obstet Gynecol 2019; 54: 182-9.
Winkler A, Tölle S, Natalucci G, Plecko B, Wisser J. Prognostic features and long-term outcome in patients with isolated fetal ventriculomegaly. Fetal Diagn Ther 2018; 44: 210-20.
Scala C, Familiari A, Pinas A, et al. Perinatal and long-term outcomes in fetuses diagnosed with isolated unilateral ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2017; 49: 450-9.
Atad-Rapoport M, Schweiger A, Lev D, Sadan-Strul S, Malinger G, Lerman-Sagie T. Neuropsychological follow-up at school age of children with asymmetric ventricles or unilateral ventriculomegaly identified in utero. BJOG 2015; 122: 932-8.
Falip C, Blanc N, Maes E, et al. Postnatal clinical and imaging follow-up of infants with prenatal isolated mild ventriculomegaly: a series of 101 cases. Pediatr Radiol 2007; 37: 981-9.
Kinzler WL, Smulian JC, McLean DA, Guzman ER, Vintzileos AM. Outcome of prenatally diagnosed mild unilateral cerebral ventriculomegaly. J Ultrasound Med 2001; 20: 257-62.
Devaseelan P, Cardwell C, Bell B, Ong S. Prognosis of isolated mild to moderate fetal cerebral ventriculomegaly: a systematic review. J Perinat Med 2010; 38: 401-9.
Tatlı B, Özer I, Ekici B, et al. Neurodevelopmental outcome of 31 patients with borderline fetal ventriculomegaly. Clin Neurol Neurosurg 2012; 114: 969-71.
Beeghly M, Ware J, Soul J, et al. Neurodevelopmental outcome of fetuses referred for ventriculomegaly. Ultrasound Obstet Gynecol 2010; 35: 405-16.
Sadan S, Malinger G, Schweiger A, Lev D, Lerman-Sagie T. Neuropsychological outcome of children with asymmetric ventricles or unilateral mild ventriculomegaly identified in utero. BJOG 2007; 114: 596-602.
Graham E, Duhl A, Ural S, Allen M, Blakemore K, Witter F. The degree of antenatal ventriculomegaly is related to pediatric neurological morbidity. J Maternal Fetal Med 2001; 10: 258-63.
Carta S, Kaelin Agten A, Belcaro C, Bhide A. Outcome of fetuses with prenatal diagnosis of isolated severe bilateral ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 52: 165-73.
Dall'Asta A, van Oostrum NHM, Basheer SN, et al. Etiology and prognosis of severe ventriculomegaly diagnosed at late gestation. Ultraschall Med 2018; 39: 675-89.
Mangione R, Fries N, Godard P, et al. Neurodevelopmental outcome following prenatal diagnosis of an isolated anomaly of the corpus callosum. Ultrasound Obstet Gynecol 2011; 37: 290-5.
DAntonio F, Pagani G, Familiari A, Khalil A, et al. Outcomes associated with isolated agenesis of the corpus callosum: a meta-analysis. Pediatrics 2016; 8: e20160445.
Sotiriadis A, Makrydimas G. Neurodevelopment after prenatal diagnosis of isolated agenesis of the corpus callosum: an integrative review. Am J Obstet Gynecol 2012; 206(4): 337.e1-5.
Brown WS, Paul LK. Cognitive and psychosocial deficits in agenesis of the corpus callosum with normal intelligence. Cogn Neuropsychiatry 2000; 5: 135-57.
Paul LK, Erickson RL, Hartman JA, Brown WS. Learning and memory in individuals with agensis of the corpus callosum. Neuropsychologia 2016; 86: 183-92.
Siffredi V, Anderson V, Leventer RJ, Spencer-Smith MM. Neuropsychological profile of agenesis of the corpus callosum: a systematic review. Dev Neuropsychol 2013; 38: 36-57.
Lau YC, Hinkley LBN, Bukshpun P, et al. Autism traits in individuals with agenesis of the corpus callosum. J Autism Dev Disord 2013; 43: 1106-18.
Badaruddin DH, Andrews GL, Bölte S, et al. Social and behavioral problems of children with agenesis of the corpus callosum. Child Psychiatry Hum Dev 2007; 38: 287-302.
Leibovitz Z, Shiran C, Haratz K, et al. Application of a novel prenatal vertical cranial biometric measurement can improve accuracy of microcephaly diagnosis in utero. Ultrasound Obstet Gynecol 2016; 47: 593-9.
Leibovitz Z, Daniel-Spiegel E, Malinger G, et al. Prediction of microcephaly at birth using three reference ranges for fetal head circumference: can we improve prenatal diagnosis? Ultrasound Obstet Gynecol 2016; 47: 586-92.
Stoler-Poria S, Lev D, Schweiger A, Lerman-Sagie T, Malinger G. Developmental outcome of isolated fetal microcephaly. Ultrasound Obstet Gynecol 2010; 36: 154-8.
Melamed N, Yogev Y, Danon D, Mashiach R, Meizner I, Ben-Haroush A. Sonographic estimation of fetal head circumference: how accurate are we? Ultrasound Obstet Gynecol 2011; 37(1): 65-71.
Woods CG, Parker A. Investigating microcephaly. Arch Dis Child 2013; 98: 707-13.
Chitty LS, Altman DG, Henderson A, Campbell S. Charts of fetal size: 2. Head measurements. Br J Obstet Gynaecol 1994; 101: 35-43.
Kurmanavicius J, Wright EM, Royston P, et al. Fetal ultrasound biometry: 1. Head reference values. Br J Obstet Gynaecol 1999; 106: 126-35.
Papageorghiou AT, Ohuma EO, Altman DG, et al. International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet 2014; 384: 869-79.
Biran-Gol Y, Malinger G, Cohen H, et al. Developmental outcome of isolated fetal macrocephaly. Ultrasound Obstet Gynecol 2010; 36: 147-53.
Baron J, Mastrolia SA, Shelef I, et al. Fetal wide subarachnoid space and its outcome in cases of macrocephaly without ventriculomegaly. J Matern Fetal Neonatal Med 2020; 33: 2570-5.
Malinger G, Lev D, Ben-Sira L, et al. Can syndromic macrocephaly be diagnosed in utero? Ultrasound Obstet Gynecol 2011; 37: 72-81.
Williams CA, Dagli A, Battaglia A. Genetic disorders associated with macrocephaly. Am J Med Genet 2008; 146A: 2023-37.
Oshima T, Hara H, Takeda N, et al. A novel mutation of NFIX causes Sotos-like syndrome (Malan syndrome) complicated with thoracic aortic aneurysm and dissection. Hum Genome Var 2017; 4: 17022.
Whiteford ML, Tolmie JL. Holoprosencephaly in the West of Scotland 1975-1994. J Med Genet 1996; 33: 578-84.
Winter TC, Kennedy AM, Woodward PJ. Holoprosencephaly: a survey of the entity, with embryology and fetal imaging. Radiographics 2015; 35: 275-90.
Barr M, Cohen MM. Holoprosencephaly survival and performance. Am J Med Genet 1999; 89: 116-20.
David AL, Gowda V, Turnbull C, Chitty LS. The risk of recurrence of holoprosencephaly in euploid fetuses. Obstet Gynecol 2007; 110: 658-62.
Levey EB, Stashinko E, Clegg NJ, Delgado MR. Management of children with holoprosencephaly. Am J Med Genet C Semin Med Genet 2010; 154C: 183-90.
Lewis AJ, Simon EM, Barkovich AJ, et al. Middle interhemispheric variant of holoprosencephaly: a distinct cliniconeuroradiologic subtype. Neurology 2002; 59: 1860-5.
Barkovich AJ, Quint DJ. Middle interhemispheric fusion: an unusual variant of holoprosencephaly. AJNR Am J Neuroradiol 1993; 14: 431-40.
Tekendo-Ngongang C, Muenke M, Kruszka P. Holoprosencephaly overview. In: Adam MP, Ardinger HH, Pagon RA, et al. editors. GeneReviews [Internet]. Seattle, WA: University of Washington; 2020. p. 1993-2020.
Orioli IM, Castilla EE. Epidemiology of holoprosencephaly: prevalence and risk factors. Am J Med Genet C Semin Med Genet 2010; 154C: 13-21.
Williams F, Griffiths PD. In utero MR imaging in fetuses at high risk of lissencephaly. Br J Radiol 2017; 90: 20160902.
Glenn OA, Cuneo AA, Barkovich AJ, Hashemi Z, Bartha AI, Xu D. Malformations of cortical development: diagnostic accuracy of fetal MR imaging. Radiology 2012; 263: 843-55.
Sato N, Yagishita A, Oba H, et al. Hemimegalencephaly: a study of abnormalities occurring outside the involved hemisphere. AJNR Am J Neuroradiol 2007; 28: 678-82.
Dobyns WB, Mirzaa GM. Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR. Am J Med Genet C Semin Med Genet 2019; 181: 582-90.
Sidira C, Vargiami E, Dragoumi P, Zafeiriou D. Hemimegalencephaly and tuberous sclerosis complex: A rare yet challenging association. Eur J Paediatr Neurol 2021; 30: 58-65.
Lang S-S, Goldberg E, Zarnow D, Johnson MP, Storm PB, Heuer GG. Prenatal diagnosis of hemimegalencephaly. World Neurosurg 2014; 82: e5-8.
Alvarez RM, García-Díaz L, Márquez J, et al. Hemimegalencephaly: prenatal diagnosis and outcome. Fetal Diagn Ther 2011; 30: 234-8.
Moosa ANV, Gupta A, Jehi L, et al. Longitudinal seizure outcome and prognostic predictors after hemispherectomy in 170 children. Neurology 2013; 80: 253-60.
Tan AP, Chong WK, Mankad K. Comprehensive genotype-phenotype correlation in lissencephaly. Quant Imaging Med Surg 2018; 8: 673-93.
Diogo MC, Glatter S, Binder J, Kiss H, Prayer D. The MRI spectrum of congenital cytomegalovirus infection. Prenat Diagn 2020; 40: 110-24.
Lacalm A, Nadaud B, Massoud M, Putoux A, Gaucherand P, Guibaud L. Prenatal diagnosis of cobblestone lissencephaly associated with Walker-Warburg syndrome based on a specific sonographic pattern. Ultrasound Obstet Gynecol 2016; 47: 117-22.
Wang CH, Bonnemann CG, Rutkowski A, et al. Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol 2010; 25: 1559-81.
Lerman-Sagie T, Leibovitz Z. Malformations of cortical development: from postnatal to fetal imaging. Can J Neurol Sci 2016; 43: 611-8.
Choi JJ, Yang E, Soul JS, Jaimes C. Fetal magnetic resonance imaging: supratentorial brain malformations. Pediatr Radiol 2020; 50: 1934-47.
Stutterd CA, Dobyns WB, Jansen A, Mirzaa G, Leventer RJ. Polymicrogyria overview. In: Adam MP, Ardinger HH, Pagon RA, et al. editors. GeneReviews [Internet]. Seattle, WA: University of Washington; 2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1329/.
Schiller S, Rosewich H, Grünewald S, Gärtner J. Inborn errors of metabolism leading to neuronal migration defects. J Inherit Metab Dis 2020; 41: 145-55.
Chang BS. Tubulinopathies and their brain malformation syndromes: every TUB on its own bottom. Epilepsy Curr 2015; 15: 65-7.
Malinger G, Lev D, Lerman-Sagie T. The fetal cerebellum: pitalls in diagnosis and management. Prenat Diagn 2009; 29: 372-80.
Zou Z, Huang L, Lin S, et al. Prenatai diagnosis of posterior fossal anomalies: additional value of chromosomal microarray analysis in fetuses with cerebellar hypoplasia. Prenat Diagn 2018; 38: 91-8.
Robinson AJ, Ederies MA. Diagnostic imaging of posterior fossa anomalies in the fetus. Semin Fetal Neonatal Med 2016; 21: 312-20.
Bosemani T, Poretti A. Cerebellar disruptions and neurodevelopmental disabilities. Semin Fetal Neonatal Med 2016; 21: 339-48.
Bolduc ME, Limperopoulos C. Neurodevelopmental outcomes in children with cerebellar malformations: a systematic review. Dev Med Child Neurol 2009; 51: 256-67.
Poretti A, Limperopoulos C, Roulet-perez E, et al. Outcome of severe unilateral cerebellar hypoplasia. Dev Med Child Neurol 2010; 52: 718-24.
D'Antonio F, Khalil A, Garel C, et al. Systematic review and meta-analysis of isolated posterior fossa malformations on prenatal imaging (part 2): neurodevelopmental outcome. Ultrasound Obstet Gynecol 2016; 48: 28-37.
Tarui T, Limperopoulos C, Sullivan N, Robertson RL, du Plessis AJ. Long-term developmental outcome of children with a fetal diagnosis of isolated inferior vermian hypoplasia. Arch Dis Child Fetal Neonatal Ed 2014; 99: F54-8.
Pugash D, Oh T, Godwin K, Robinson AJ, Byrne A, Van Allen MI, Osiovich H. Sonographic 'molar tooth' sign in the diagnosis of Joubert syndrome. Ultrasound Obstet Gynecol 2011; 38: 598-602.
Appasamy M, Roberts D, Pilling D, Buxton N. Antenatal ultrasound and magnetic resonance imaging in localizing the level of lesion in spina bifida and correlation with postnatal outcome. Ultrasound Obstet Gynecol 2006; 27: 530-6.
Sherrod BA, Ho WS, Hedlund A, Kennedy A, Ostrander B, Bollo RJ. A comparison of the accuracy of fetal MRI and prenatal ultrasonography at predicting lesion level and perinatal motor outcome in patients with myelomeningocele. Neurosurg Focus 2019; 47: E4.
Nagaraj UD, Bierbrauer KS, Stevenson CB, et al. Spinal imaging findings of open spinal dysraphisms on fetal and postnatal MRI. AJNR Am J Neuroradiol 2018; 39: 1947-52.
North T, Cheong A, Steinbok P, Radic JA. Trends in incidence and long-term outcomes of myelomeningocele in British Columbia. Childs Nerv Syst 2018; 34: 717-24.
Williams EN, Broughton NS, Menelaus MB. Age-related walking in children with spina bifida. Dev Med Child Neurol 1999; 41: 446-9.
Beuriat P-A, Poirot I, Hameury F, et al. Postnatal management of myelomeningocele: outcome with a multidisciplinary team experience. World Neurosurg 2018; 110: e24-31.
Oakeshott P, Poulton A, Hunt GM, Reid F. Walking and living independently with spina bifida: a 50-year prospective cohort study. Dev Med Child Neurol 2019; 61: 1202-7.
Dennis M, Salman MS, Jewell D, et al. Upper limb motor function in young adults with spina bifida and hydrocephalus. Childs Nerv Syst 2009; 25: 1447-53.
Spoor JKH, Gadjradj PS, Eggink AJ, et al. Contemporary management and outcome of myelomeningocele: the Rotterdam experience. Neurosurg Focus 2019; 47: E3.
McCarthy DJ, Sheinberg DL, Luther E, McCrea HJ. Myelomeningocele-associated hydrocephalus: nationwide analysis and systematic review. Neurosurg Focus 2019; 47: E5.
Bowman RM, Boshnjaku V, McLone DG. The changing incidence of myelomeningocele and its impact on pediatric neurosurgery: a review from the Children’s Memorial Hospital. Childs Nerv Syst 2009; 25: 801-6.
Chakraborty A, Crimmins D, Hayward R, Thompson D. Toward reducing shunt placement rates in patients with myelomeningocele. J Neurosurg Pediatr 2008; 1: 361-5.
Kim I, Hopson B, Aban I, et al. Decompression for Chiari Malformation type II in individuals with myelomeningocele in the National Spina Bifida Patient Registry. J Neurosurg Pediatr 2018; 22: 652-8.
Casari EF, Fantino AG. A longitudinal study of cognitive abilities and achievement status of children with myelomeningocele and their relationship with clinical types. Eur J Pediatr Surg 1998; 8: 52-4.
Lindquist B, Uvebrant P, Rehn E, Carlsson G. Cognitive functions in chidren with myelomeningocele without hydrocephalus. Childs Nerv Syst 2009; 25: 969-75.
Nejat F, Kazmi SS, Habibi Z, Tajik P, Shahrivar Z. Intelligence quotient in children with meningomyeloceles: a case-control study. J Neurosurg 2007; 106: 106-10.
Vinck A, Mullaart R, Rotteveel J, Maassen B. Neuropsychological assessment of attention in children with spina bifida. Cerebrospinal Fluid Res 2009; 6: 6.
Müller-Godeffroy E, Michael T, Poster M, Seidel U, Schwarke D, Thyen U. Self-reported health-related quality of life in children and adolescents with myelomeningocele. Dev Med Child Neurol 2008; 50: 456-61.
De la Torre GG, Martin A, Cervantes E, Guil R, Mestre JM. Attention lapses in children with spina bifida and hydrocephalus and children with attention-deficit/hyperactivity disorder. J Clin Exp Neuropsychol 2017; 39: 563-73.
Burmeister R, Hannay HJ, Copeland K, Fletcher JM, Boudousquie A, Dennis M. Attention problems and executive functions in children with spina bifida and hydrocephalus. Child Neuropsychol 2005; 11: 265-83.
Cope H, McMahon K, Heise E, et al. Outcome and life satisfaction of adults with myelomeningocele. Disabil Health J 2013; 6: 236-43.
Mahone EM, Zabel TA, Levey E, Verda M, Kinsman S. Parent and self-report ratings of executive function in adolescents with myelomeningocele and hydrocephalus. Child Neuropsychol 2002; 8: 258-70.
Wiener JS, Suson KD, Castillo J, et al. Bladder Management and continence outcomes in adults with spina bifida: results from the National Spina Bifida Patient Registry, 2009 to 2015. J Urol 2018; 200: 187-94.
Johnston AW, Wiener JS, Purves JT. Pediatric neurogenic bladder and bowel dysfunction: Will my child ever be out of diapers? Eur Urol Focus 2020; 6: 838-67.
Liu T, Ouyang L, Thibadeau J, et al. Longitudinal study of bladder continence in patients with spina bifida in the National Spina Bifida Patient Registry. J Urol 2018; 199: 837-43.
Verhoef M, Barf HA, Post MWM, van Asbeck FWA, Gooskens RHJM, Prevo AJH. Functional independence among young adults with spina bifida, in relation to hydrocephalus and level of lesion. Dev Med Child Neurol 2006; 48: 114-9.
Wiener JS, Suson KD, Castillo J, et al. Bowel management and continence in adults with spina bifida: results from the National Spina Bifida Patient Registry 2009-15. J Pediatr Rehabil Med 2017; 10: 335-43.
Choi EK, Im YJ, Han SW. Bowel management and quality of life in children with spina bifida in South Korea. Gastroenterol Nurs 2017; 40: 208-15.
Rocque BG, Bishop ER, Scogin MA, et al. Assessing health-related quality of life in children with spina bifida. J Neurosurg Pediatr 2015; 15: 144-9.
Bakaniene I, Prasauskiene A. Patterns and predictors of participation in children and adolescents with spina bifida. Disabil Rehabil 2019; 42: 3771-9.
Beuriat P-A, Poirot I, Hameury F, et al. Postnatal management of myelomeningocele: outcome with a multidisciplinary team experience. World Neurosurg 2018; 110: e24-31.
Parisi CA, Petriz NA, Busaniche JN, et al. Prevalence of latex allergy in a population of patients diagnosed with myelomeningocele. Arch Argent Pediatr 2016; 114: 30-5.
Rendeli C, Nucera E, Ausili E, et al. Latex sensitisation and allergy in children with myelomeningocele. Childs Nerv Syst 2006; 22: 28-32.
Shah S, Cawley M, Gleeson R, O'Connor J, McGeady S. Latex allergy and latex sensitization in children and adolescents with meningomyelocele. J Allergy Clin Immunol 1998; 101: 741-6.
Patel DM, Rocque BG, Hopson B, et al. Sleep-disordered breathing in patients with myelomeningocele. J Neurosurg Pediatr 2015; 16: 30-5.
Crytzer TM, Cheng Y-T, Bryner MJ, Wilson III R, Sciurba FC, Dicianno BE. Impact of neurological level and spinal curvature on pulmonary function in adults with spina bifida. J Pediatr Rehabil Med 2018; 11: 243-54.
Roach JW, Short BF, Saltzman HM. Adult consequences of spina bifida. Clin Orthop Relat Res 2011; 469: 1246.
Lassmann J, Garibay Gonzalez F, Melchionni JB, Pasquariello PS Jr, Snyder HM 3rd. Sexual function in adult patients with spina bifida and its impact on quality of life. J Urol 2007; 178: 1611-4.
Decter RM, Furness PD, Nguyen TA, McGowan M, Laudermilch C, Telenko A. Reproductive understanding, sexual functioning and testosterone levels in men with spina bifida. J Urol 1997; 157: 1466-8.
Choi EK, Ji Y, Han SW. Sexual function and quality of life in young men with spina bifida: could it be neglected aspects in clinical practice? Urology 2017; 108: 225-32.
Deng N, Thirumavalavan N, Beilan JA, et al. Sexual dysfunction and infertilty in the male spina bifida patient. Transl Androl Urol 2018; 7: 941-9.
Gamé X, Moscovici J, Gamé L, Sarramon J-P, Rischmann P, Malavaud B. Evaluation of sexual function in young men with spina bifida and myelomeningocele using the International Index of Erectile Function. Urology 2006; 67: 566-70.
Hirayama A, Yamada K, Tanaka Y, et al. Evaluation of sexual function in adults with myelomeningocele. Hinyokika Kiyo 1995; 41: 985-9.
Roth JD, Misseri R, Cain MP, Szymanski KM. Mobility, hydrocephalus and quality of erections in men with spina bifida. J Pediatr Urol 2017; 13(3): 264.e1-6.
Palmer JS, Kaplan WE, Firlit CF. Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol 2000; 164: 958-61.
Choi EK, Kim SW, Ji Y, Lim SW, Han SW. Sexual function and qualify of life in women with spina bifida: are the women with spina bifida satisfied with their sexual activity? Neurourol Urodyn 2018; 37: 1785-93.
Gamé X, Moscovici J, Guillotreau J, Roumiguié M, Rischmann P, Malavaud B. Sexual function of young women with myelomeningocele. J Pediatr Urol 2014; 10: 418-23.
Houtrow AJ, Thom EA, Fletcher JM, et al. Prenatal repair of myelomeningocele and school-age functional outcomes. Pediatrics 2020; 145: e20191544.
Farmer DL, Thom EA, Brock JW, et al. The management of myelomeningocele study: full cohort 30-month pediatric outcomes. Am J Obstet Gynecol 2018; 256: e1-e13.
Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011; 364: 993-1004.
Ouahba J, Luton D, Vuillard E, et al. Prenatal isolated mild ventriculomegaly: outcome in 167 cases. BJOG 2006; 113: 1072-9.
Folliot-Le Doussal L, Chadie A, Brasseur-Daudruy M, Verspyck E, Saugier-Veber P, Marret S. Neurodevelopmental outcome in prenatally diagnosed isolated agenesis of the corpus callosum. Early Hum Dev 2018; 116: 9-16.
Yeh H-R, Park H-K, Kim H-J, et al. Neurodevelopmental outcomes in children with prenatally diagnosed corpus callosal abnormalities. Brain Dev 2018; 40: 634-41.
des Portes V, Rolland A, Velazquez-Dominguez J, et al. Outcome of isolated agenesis of the corpus callosum: a population-based prospective study. Eur J Paediatr Neurol 2018; 22: 82-92.
Chadie A, Radi S, Trestard L, Charollais A, Eurin D, Verspyck E, Haute-Normandie Perinatal Network. Neurodevelopmental outcome in prenatally diagnosed isolated agenesis of the corpus callosum. Acta Paediatr 2008; 97: 420-4.